E

electroCore

ECOR

6.01000
USD
0.06
(1.01%)
Market Closed
Volume
600
EPS
0
Div Yield
0
P/E
-5
Market Cap
64,984,409
Related Instruments
A
AMRN
-0.06090
(-8.93%)
0.62120 USD
A
ATEC
-3.48000
(-34.35%)
6.65000 USD
C
CHE
17.17
(3.01%)
587.98 USD
E
EXAS
12.150
(26.55%)
57.910 USD
L
LMAT
-1.050
(-1.21%)
85.950 USD
R
RVP
-0.03000
(-2.54%)
1.15000 USD
R
RXDX
1.230
(1.09%)
113.430 USD
V
VICR
-2.700
(-6.40%)
39.500 USD
News

Title: electroCore

Sector: Healthcare
Industry: Medical Devices
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated withmigraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.